Alcon (NYSE:ALC) stock continues to decline as J.P. Morgan downgrades the company following mixed Q2 2025 results and lowered sales guidance. Read more here.

H.C. Wainwright upgraded CoreWeave (CRWV) to Buy from Neutral with an $180 price target. The stock's valuation "has sunk deep enough," the analyst tells investors in a research note. Arete also ...

Alcon affirmed fiscal year 2025 adjusted earnings of $3.05-$3.15 versus consensus of $3.12. The company lowered 2025 sales guidance from $10.4 billion-$10.5 billion to $10.3 billion-$10.4 billion, ...

Aegon (NYSE: AEG) ADRs rose 5.5% after the Dutch insurer doubled the planned value of its ongoing share buyback program, which it aims to conclude by the end of 2025, and said it was studying the ...

Alcon AG (NYSE:ALC) saw its stock fall more than 2% on Thursday following a rating cut by J.P. Morgan, citing disappointing quarterly performance and reduced visibility on earnings. David Adlington, ...

The analysts cut its rating on Alcon shares to “neutral” from “overweight” and lowered its price target to SFr 62.8 for June 2027, down from SFr 94.7 for June 2026. The reduced target reflects lower ...

JPMorgan analyst David Adlington downgraded Alcon (ALC) to Neutral from Overweight with a price target of $77.53, down from $105.88. The company ...